Search Results - "Koczka, Kim"

Comparative transcriptomics of Atlantic Salmo salar, chum Oncorhynchus keta and pink salmon O. gorbuscha during infections with salmon lice Lepeophtheirus salmonis by Sutherland, Ben J G, Koczka, Kim W, Yasuike, Motoshige, Jantzen, Stuart G, Yazawa, Ryosuke, Koop, Ben F, Jones, Simon R M

“…Salmon species vary in susceptibility to infections with the salmon louse (Lepeophtheirus salmonis). Comparing mechanisms underlying responses in susceptible…”
Get full text

Docetaxel dose-intensity effect on overall survival in patients with metastatic castrate-sensitive prostate cancer by Kushnir, Igal, Mallick, Ranjeeta, Ong, Michael, Canil, Christina, Bossé, Dominick, Koczka, Kim, Reaume, Neil M.

“…Background Several studies assessed the association of docetaxel dose intensity (DI) and efficacy in metastatic castrate-resistant prostate cancer (mCRPC)…”
Get full text

Comparing the associations between host and tumor factors with survival outcomes with anti‐PD‐1 immunotherapy in metastatic melanoma by Koczka, Kim, Rigo, Rodrigo, Batuyong, Eugene, Cook, Sara, Asad, Mohammad, Vallerand, Isabelle, Suo, Aleksi, Wang, Edwin, Cheng, Tina

“…Background Anti‐programmed death‐1 (PD‐1) immunotherapy has drastically improved survival for metastatic melanoma; however, 50% of patients have progression…”
Get full text

The timing of docetaxel initiation in metastatic castrate-sensitive prostate cancer and the rate of chemotherapy-induced toxicity by Kushnir, Igal, Koczka, Kim, Ong, Michael, Canil, Christina, Bossé, Dominick, Sabri, Elham, Reaume, M.Neil

“…Docetaxel pharmacokinetics are affected by androgen deprivation therapy (ADT), which is attributed to changes in liver metabolism induced by castration. In…”
Get full text

Real World Outcomes in Patients with Advanced Melanoma Treated in Alberta, Canada: A Time-Era Based Analysis by Rigo, Rodrigo, Doherty, Jordan, Koczka, Kim, Kong, Shiying, Ding, Philip Q., Cheng, Tina, Cheung, Winson Y., Monzon, Jose G.

“…Immune checkpoint and MAP kinase pathway inhibitors can significantly improve long-term survival for patients with melanoma. There is limited real-world data…”
Get full text

Real-world impact of TAILORx on chemotherapy use and SOFT/TEXT on ovarian function suppression uptake in a population based-cohort of women 40 years and under with HR-positive, HER2-negative, axillary lymph node negative breast cancer by Hannouf, Malek B., Koczka, Kim, Brackstone, Muriel, Lupichuk, Sasha M.

“…534 Background: Gene expression profiling (GEP) testing is prognostic for distant recurrence risk in women with hormone receptor positive (HR+), human…”
Get full text

Host–parasite transcriptomics during immunostimulant-enhanced rejection of salmon lice ( Lepeophtheirus salmonis ) by Atlantic salmon ( Salmo salar ) by Sutherland, Ben J.G., Covello, Jennifer M., Friend, Sarah E., Poley, Jordan D., Koczka, Kim W., Purcell, Sara L., MacLeod, Tara L., Donovan, Bridget R., Pino, Jorge, González-Vecino, Jose Luis, Gonzalez, Javier, Troncoso, Jose, Koop, Ben F., Wadsworth, Simon L., Fast, Mark D.

“…Salmon lice ( Lepeophtheirus salmonis) are important ectoparasites of wild and farmed salmonids and cause major losses to the salmon farming industry…”
Get full text

Prognostic pathological and clinical factors associated with overall survival in metastatic melanoma undergoing anti PD-1 treatment by Koczka, Kim, Rigo, Rodrigo, Suo, Aleksi, Asad, Mohammad, Wang, Edwin, Batuyong, Eugene, Cheng, Tina

“…Abstract only e21531 Background: Anti-PD-1 immunotherapy has revolutionized metastatic melanoma treatment, as first-line monotherapy or in combination with…”
Get full text

Adjuvant systemic therapies for melanoma in Alberta: An early descriptive analysis of population characteristics and treatment outcomes by Rigo, Rodrigo, Koczka, Kim, Batra, Atul, Cheung, Winson Y., Monzon, Jose Gerard, Cheng, Tina

“…Abstract only e22013 Background: Adjuvant immunotherapies and adjuvant targeted therapy for melanoma became available in clinical practice in 2018 in Alberta,…”
Get full text

Docetaxel dose-intensity effect on overall survival in patients with metastatic castrate-sensitive prostate cancer by Kushnir, Igal, Mallick, Ranjeeta, Ong, Michael, Canil, Christina, Bossé, Dominick, Koczka, Kim, Reaume, M. Neil

“…Abstract only e16501 Background: Several studies assessed the association of docetaxel dose intensity (DI) and efficacy in metastatic castrate-resistant…”
Get full text

The timing of docetaxel initiation in metastatic castrate sensitive prostate cancer and the rate of chemotherapy induced toxicity by Kushnir, Igal, Koczka, Kim, Ong, Michael, Canil, Christina M., Sabri, Elham, Reaume, M. Neil

“…Abstract only…”
Get full text

Influence of aggressive-variant prostate cancer (AVPC) features on outcome of metastatic hormone-sensitive prostate cancer (mHSPC) treated by chemohormonal therapy (CHT) by Koczka, Kim, Vanhie, James, Ibrahim, Andrea, Bukhari, Nedal, Reaume, M. Neil, Sehdev, Sandeep R., Potvin, Kylea R., Sax, Lori, Ernst, D. Scott, Vickers, Michael M., Canil, Christina M., Winquist, Eric, Ong, Michael

“…Abstract only 193 Background: Outcomes of patients (pts) undergoing CHT for mHSPC are heterogeneous, with some rapidly developing castration-resistance (CRPC)…”
Get full text